Tag Archives: Financial

Viewpoints: Stop Talking About Expanding Medicare. Fix Its Financial Flaws Instead; Why Do We Need Anymore Lessons On The Societal Risks Of Genome Editing?

Editorial writers weigh in on these health topics and others. The Wall Street Journal: Modest Cuts Could Save Medicare From Disaster Instead of debating how to expand Medicare coverage, politicians should focus on fixing the fatal financial flaws in the existing program that threaten to bankrupt the nation. Medicare spent 3.6% of gross domestic product… Read More »

Top Cancer Researcher Fails to Disclose Corporate Financial Ties in Major Research Journals

Board of Directors ■ Aura Biosciences* (cancer startup) ■ Bristol-Myers Squibb ■ Foghorn Therapeutics (cancer startup) ■ Grail* (cancer testing startup) ■ Infinity Pharmaceuticals* (cancer startup) ■ Varian Medical Systems (radiation equipment) Scientific or Clinical Advisory Board ■ ApoGen Biotechnologies (cancer startup) ■ Aura Biosciences (cancer startup) ■ Grail (cancer testing startup) ■ Juno Therapeutics*… Read More »